mesheuropmc: complex mixtures | cardiovascular system | musculoskeletal system | cardiovascular diseases
Cardiovascular disease is a leading cause of death in both humans and dogs. Dilated cardiomyopathy (DCM) accounts for a large number of these cases, reported to be the third most common form of cardiac disease in humans and the second most common in dogs. In human studi... View more
 J. M. Fleming, K. E. Creevy, and D. E. L. Promislow, “Mortality in north american dogs from 1984 to 2004: an investigation into age-, size-, and breed-related causes of death,” Journal of Veterinary Internal Medicine, vol. 25, no. 2, pp. 187-198, 2011.
 C. D. Mathers and D. Loncar, “Projections of global mortality and burden of disease from 2002 to 2030,” PLoS Medicine, vol. 3, no. 11, article e442, 2006.
 A. Egenvall, B. N. Bonnett, and J. Ha¨ggstro¨m, “Heart disease as a cause of death in insured Swedish dogs younger than 10 years of age,” Journal of Veterinary Internal Medicine, vol. 20, no. 4, pp. 894-903, 2006.
 H. Raju, C. Alberg, G. S. Sagoo, H. Burton, and E. R. Behr, “Inherited cardiomyopathies,” British Medical Journal, vol. 343, Article ID d6966, 2011.
 R. E. Hershberger, A. Morales, and J. D. Siegfried, “Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals,” Genetics in Medicine, vol. 12, no. 11, pp. 655-667, 2010.
 T.-B. Mausberg, G. Wess, J. Simak et al., “A locus on chromosome 5 is associated with dilated cardiomyopathy in doberman pinschers,” PLoS ONE, vol. 6, no. 5, Article ID e20042, 2011.
 J. A. Dixon and F. G. Spinale, “Large animal models of heart failure: a critical link in the translation of basic science to clinical practice,” Circulation: Heart Failure, vol. 2, no. 3, pp. 262-271, 2009.
 F. G. Akar, R. C. Wu, G. J. Juang et al., “Molecular mechanisms underlying K+ current downregulation in canine tachycardiainduced heart failure,” eTh American Journal of PhysiologyHeart and Circulatory Physiology, vol. 288, no. 6, pp. H2887- H2896, 2005.
 M. Argenziano and M. L. Dickstein, “Cardiovascular eefcts of inhaled nitric oxide in a canine model of cardiomyopathy,” eTh Annals of oThracic Surgery , vol. 69, no. 5, pp. 1644-1645, 2000.
 Y. Toyoda, M. Okada, and M. A. Kashem, “A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration,” Journal of oThracic and Cardiovascular Surgery, vol. 115, no. 6, pp. 1367-1373, 1998.